Francois Cedric Insider Trades

Insider Trading History

Track insider trading activity for Francois Cedric. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$9.62M 234,411 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$77.7M 1,893,658 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Executive Officer
Holding Value $8.04M 195,952 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21.5M 524,786 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Executive Officer
Holding Value $15.3M 372,815 shares
Last Trade
Mar 11, 2026 Purchase (Gift)Shares transferred as a gift rather than bought or sold for cash.
$1.26M 64,869 shares
$19.38
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Executive Officer
Holding Value $17.5M 425,968 shares
Last Trade
Mar 11, 2026 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$1.26M 64,869 shares
$19.38
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Executive Officer
Holding Value $20.1M 490,837 shares
Last Trade
Feb 03, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$202k 8,840 shares
$22.83
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Feb 03, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$202k 8,840 shares
$22.83
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Executive Officer
Holding Value $19.8M 481,997 shares
Last Trade
Jan 28, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.24M 195,952 shares
$21.63
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Executive Officer
Holding Value $11.7M 286,045 shares
Last Trade
Jan 22, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$592k 27,192 shares
$21.77
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Executive Officer
Holding Value $12.9M 313,237 shares
Last Trade
Jan 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$162k 8,182 shares
$19.79
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Executive Officer
Holding Value $13.2M 321,419 shares
Last Trade
Jan 13, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$226k 10,186 shares
$22.19
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Executive Officer
Holding Value $12.6M 307,946 shares
Last Trade
Aug 28, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.42M 49,963 shares
$28.39
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Executive Officer
Holding Value $14.7M 357,909 shares
Last Trade
Aug 27, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.93M 175,037 shares
$28.19
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Executive Officer
Holding Value $13.6M 331,605 shares
Last Trade
Jul 17, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$399k 19,725 shares
$20.21
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Executive Officer
Holding Value $4.13M 100,538 shares
Last Trade
Jul 17, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$180k 8,997 shares
$20.04
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Executive Officer
Holding Value $14.4M 351,330 shares
Last Trade
Jul 17, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$180k 8,997 shares
$20.04
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Executive Officer
Holding Value $14M 342,333 shares
Last Trade
Jul 15, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$38.2k 1,900 shares
$20.09
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Executive Officer
Holding Value $14.1M 344,233 shares
Last Trade
Jul 15, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$15.5k 800 shares
$19.35
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Executive Officer
Holding Value $4.49M 109,535 shares
Last Trade
Jul 15, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$15.5k 800 shares
$19.35
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Executive Officer
Holding Value $19.7M 480,898 shares
Last Trade
Jul 14, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.3M 65,203 shares
$19.91
$41.03

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up